T
44
3
DHR
45
-5
SEE
41
-3
INTU
66
3
PFG
46
3
AMZN
63
5
LUV
63
-2
HBI
30
-7
LRCX
80
-4
HPE
53
-2
MRO
38
4
AN
44
-6
HRL
29
5
TMO
54
-2
IR
77
-2
RL
80
2
SLB
48
3
PYPL
37
4
KEY
36
3
VNO
54
-2
T
44
3
DHR
45
-5
SEE
41
-3
INTU
66
3
PFG
46
3
AMZN
63
5
LUV
63
-2
HBI
30
-7
LRCX
80
-4
HPE
53
-2
MRO
38
4
AN
44
-6
HRL
29
5
TMO
54
-2
IR
77
-2
RL
80
2
SLB
48
3
PYPL
37
4
KEY
36
3
VNO
54
-2
Financhill
Back

Western Alliance Bancorp Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
56

WAL
Western Alliance Bancorp

Last Price:
58.97
Seasonality Move:
6.32%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
56
Western Alliance Bancorp (WAL) is a Buy

Is Western Alliance Bancorp a Buy, Sell or Hold?

  • The current Western Alliance Bancorp [WAL] share price is $59.68. The Score for WAL is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • WAL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WAL Stock Price Chart

What is Western Alliance Bancorp's stock price today?

  • The Western Alliance Bancorp share price today is $59.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WAL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

WAL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 46.66 Sell
Chaikin Money Flow: 347938 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.05 - 63.75) Sell
Bollinger Bands (100): (57.6 - 63.08) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

WAL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.29 Buy
20-day SMA: 60.59 Sell
50-day SMA: 60.38 Sell
200-day SMA: 56.31 Buy
8-day EMA: 59.6 Buy
20-day EMA: 60.28 Sell
50-day EMA: 60.6 Sell
200-day EMA: 57.71 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Western Alliance Bancorp Earnings Growth & WAL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.41 per share, and an increase next year of $1.74 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Western Alliance Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):